Principal Financial Group Inc Collegium Pharmaceutical, Inc Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 1,573,356 shares of COLL stock, worth $46.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,573,356

Previous 1,645,051 4.36%

Holding current value

$46.1 Million

Previous $47.1 Million 0.35%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$28.04 - $33.91 $2.01 Million - $2.43 Million	-71,695 Reduced 4.36%	1,573,356 $47 Million
Q4 2024 Jan 31, 2025	BUY	$28.61 - $41.86 $47.1 Million - $68.9 Million	1,645,051 New	1,645,051 $47.1 Million
Q3 2024 Oct 31, 2024	BUY	$31.4 - $39.07 $2.04 Million - $2.54 Million	64,958 Added 3.86%	1,745,818 $67.5 Million
Q2 2024 Jul 29, 2024	BUY	$31.36 - $39.99 $4.01 Million - $5.12 Million	128,003 Added 8.24%	1,680,860 $54.1 Million
Q1 2024 Apr 29, 2024	SELL	$31.23 - $40.91 $508,861 - $666,587	-16,294 Reduced 1.04%	1,552,857 $60.3 Million
Q4 2023 Feb 07, 2024	SELL	$21.16 - $30.8 $213,483 - $310,741	-10,089 Reduced 0.64%	1,569,151 $48.3 Million
Q3 2023 Nov 02, 2023	SELL	$21.23 - $24.28 $86,045 - $98,406	-4,053 Reduced 0.26%	1,579,240 $35.3 Million
Q2 2023 Aug 07, 2023	BUY	$21.06 - $24.0 $679,290 - $774,120	32,255 Added 2.08%	1,583,293 $34 Million
Q1 2023 May 09, 2023	SELL	$23.0 - $29.88 $2.76 Million - $3.59 Million	-120,029 Reduced 7.18%	1,551,038 $37.2 Million
Q4 2022 Feb 09, 2023	SELL	$16.14 - $23.55 $1.48 Million - $2.16 Million	-91,533 Reduced 5.19%	1,671,067 $38.8 Million
Q3 2022 Nov 09, 2022	BUY	$15.46 - $20.1 $375,817 - $488,610	24,309 Added 1.4%	1,762,600 $28.2 Million
Q2 2022 Aug 10, 2022	BUY	$14.22 - $20.88 $4.56 Million - $6.7 Million	320,778 Added 22.63%	1,738,291 $30.8 Million
Q1 2022 May 09, 2022	BUY	$17.2 - $22.5 $1.92 Million - $2.51 Million	111,770 Added 8.56%	1,417,513 $28.9 Million
Q4 2021 Feb 09, 2022	BUY	$17.5 - $21.35 $4.34 Million - $5.3 Million	248,132 Added 23.46%	1,305,743 $24.4 Million
Q3 2021 Nov 09, 2021	BUY	$17.75 - $25.39 $455,891 - $652,116	25,684 Added 2.49%	1,057,611 $20.9 Million
Q2 2021 Aug 10, 2021	BUY	$21.74 - $25.28 $7.04 Million - $8.19 Million	323,854 Added 45.74%	1,031,927 $24.4 Million
Q1 2021 May 10, 2021	BUY	$19.25 - $26.1 $6.42 Million - $8.71 Million	333,737 Added 89.15%	708,073 $16.8 Million
Q4 2020 Feb 08, 2021	BUY	$17.83 - $22.29 $6.67 Million - $8.34 Million	374,336 New	374,336 $7.5 Million

Others Institutions Holding COLL

# of Institutions

254

Shares Held

37.2M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Collegium Pharmaceutical, Inc Transaction History